{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-22-000138","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.107089+00:00","generated_at":"2026-06-22T04:56:06.745252+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Masimo Q3 revenue $549M beat; healthcare grows 10% constant currency; guides FY above prior","bullets":["Consolidated revenue $549.3M (+78.7% YoY); healthcare revenue $327.2M (+6.4% reported, +10% constant currency).","GAAP net income $37.9M ($0.70 diluted EPS); Non-GAAP net income $53.9M ($1.00 diluted EPS).","Q4 guidance: revenue $581-611M; GAAP EPS $0.80-0.92, Non-GAAP $1.11-1.22.","Full-year FY2022 guidance raised: revenue $2,000-2,030M; GAAP EPS $2.65-2.76, Non-GAAP $4.38-4.49.","Non-healthcare (Sound United) revenue $222.1M; management cites strong performance in challenging environment."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-22-000138","json":"https://secwatch.observer/filing/0000937556-22-000138.json","markdown":"https://secwatch.observer/filing/0000937556-22-000138.md","text":"https://secwatch.observer/filing/0000937556-22-000138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755622000138/0000937556-22-000138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755622000138/masi-20221108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T04:56:06.745252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f0fc6bbfd41d9fe4dcc380c925037b659bb217da","claim":"MASIMO CORP reported the third quarter of 2022, ended October 1, 2022 results: revenue $549.3 million, net income $37.9 million, EPS $0.70 per diluted share.","evidence_excerpt":"Consolidated revenue was $549.3 million, representing 78.7% reported growth compared to $307.4 million in the third quarter of 2021. Healthcare revenue was $327.2 million, which represents 6.4% reported growth and 10.0% growth on a constant currency basis. Non-healthcare revenue wa s $222.1 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments wer e 76,100. For the third quarter of 2022, on a consolidated basis, GAAP net income was $37.9 million, or $0.70 per diluted share, which includes expenses related to the Sound United acquisition.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755622000138/0000937556-22-000138-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2022, ended October 1, 2022"},{"label":"Revenue","value":"$549.3 million"},{"label":"Net income","value":"$37.9 million"},{"label":"EPS","value":"$0.70 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}